Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
Since the first reports from December 2019, COVID-19 caused an overwhelming global pandemic that has affected 223 countries, seriously endangering public health and creating an urgent need for effective drugs to treat SARS-CoV-2 infection. Currently, there is a lack of safe, effective, and specific...
Saved in:
Main Authors: | Lei Zhao (Author), Song Li (Author), Wu Zhong (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022) -
Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics
by: Chris Chun-Yiu Chan, et al.
Published: (2024) -
Reducing SARS-CoV-2 pathological protein activity with small molecules
by: Donata Pluskota-Karwatka, et al.
Published: (2021) -
Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
by: Wei Chen, et al.
Published: (2021) -
Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022)